Abciximab improves 6-month clinical outcome after rescue coronary angioplasty.

Abstract

BACKGROUND Few data are available concerning the effects on clinical outcome and left ventricular function of abciximab administration in patients undergoing rescue percutaneous transluminal coronary angioplasty (PTCA) after failed thrombolysis for acute myocardial infarction. The aim of the study was to investigate such effects. METHODS Eighty-nine… (More)

Topics

Cite this paper

@article{Petronio2002AbciximabI6, title={Abciximab improves 6-month clinical outcome after rescue coronary angioplasty.}, author={Anna Sonia Petronio and Giuseppe Musumeci and Ugo Limbruno and Marco de Carlo and Roberto Baglini and Giovanni Paterni and Maria Grazia Delle Donne and Paolo Caravelli and Carmela Nardi and Mario Mariani}, journal={American heart journal}, year={2002}, volume={143 2}, pages={334-41} }